Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
731.30
-16.20 (-2.17%)
At close: Dec 4, 2025
2.05%
Market Cap 1.76B
Revenue (ttm) 193.90M
Net Income (ttm) 4.82M
Shares Out 2.40M
EPS (ttm) 2.01
PE Ratio 364.10
Forward PE n/a
Dividend 1.00 (0.14%)
Ex-Dividend Date Nov 23, 2025
Volume 1,663
Average Volume 1,205
Open 741.00
Previous Close 747.50
Day's Range 730.00 - 741.00
52-Week Range 675.00 - 947.90
Beta -0.39
RSI 32.24
Earnings Date Jan 21, 2026

About Ambee Pharmaceuticals

Ambee Pharmaceuticals PLC engages in the manufacture, buy, sell, export, or deal in drugs, medicines, pharmaceuticals, chemicals, medical, and other preparations in Bangladesh. The company offers tablets, capsules, liquids, gel in tubes, and injectables for therapeutic areas, such as antiulcerant, antacid, antibacterial, antifungal, anti-protozoal, anti-helmintic, antituberculer, antispasmodic, antiasthmatic and antitussive, and analgesic and antipyretic. It also provides products for therapeutic areas in non-steroidal anti-inflammatory, steroi... [Read more]

Industry Pharmaceutical Preparations
Founded 1976
Employees 474
Stock Exchange Dhaka Stock Exchange
Ticker Symbol AMBEEPHA
Full Company Profile

Financial Performance

In 2025, Ambee Pharmaceuticals's revenue was 230.55 million, an increase of 5.13% compared to the previous year's 219.30 million. Earnings were 5.31 million, a decrease of -45.17%.

Financial Statements

News

There is no news available yet.